Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple blood test could spot pancreatic cancer before symptoms start

NCT ID NCT07605819

Diagnosis Sponsor: Cosomil, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new blood test called Enzeavour that looks for tiny signs of pancreatic cancer in healthy people. About 10,000 adults in Japan getting routine checkups will give a blood sample. If the test shows a high score, they will get further imaging to check for cancer. The goal is to see if this test can find pancreatic cancer early, when it's easier to treat.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enzeavour Pancreatic Cancer Assay (blood test measuring enzyme activity)
What this could lead to
If successful, this blood test could become a routine screening tool to catch pancreatic cancer early, when treatment is more likely to work.
What could go wrong
This is an early feasibility study, not a final proof. The test may produce false positives or miss some cancers, and results may not apply outside Japan.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Asymptomatic adults attending participating facilities for routine health checkups, organized cancer screening, or both * Able to understand the study procedures and provide written informed consent before enrollment Exclusion Criteria: * Documented clinical history of pancreatic cancer * Considered unable or unwilling to undergo any required diagnostic imaging modality (MRCP, EUS, or contrast-enhanced CT) after a positive index test result * Any medical, psychological, or social condition that, in the opinion of the principal investigator at each participating site, makes participation inappropriate or compromises study integrity

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pancreatic cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pancreatic cancer Pancreatic neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    48 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aichi Medical University Hospital

    RECRUITING

    Nagakute, Aichi-ken, Japan

  • C'est la vie Shinbashi Clinic

    RECRUITING

    Itabashi-ku, Tokyo, Japan

  • Clinic Green House

    RECRUITING

    Kochi, Kochi, Japan

  • Hiroshima University Hospital

    RECRUITING

    Hiroshima, Hiroshima, Japan

  • Hotel Okura Kobe Clinic

    RECRUITING

    Kobe, Hyōgo, Japan

  • Ibaraki Medical Center

    RECRUITING

    Mito, Ibaraki, Japan

  • Isehara Kyodo Hospital

    RECRUITING

    Isehara, Kanagawa, Japan

  • JA Health Management Center Atsugi

    RECRUITING

    Atsugi, Kanagawa, Japan

  • JA Health Management Center Sagamihara

    RECRUITING

    Sagamihara, Kanagawa, Japan

  • JA Onomichi General Hospital

    RECRUITING

    Onomichi, Hiroshima, Japan

  • Japanese RedCross Society Kochi Red Cross Hospital

    RECRUITING

    Kochi, Kochi, Japan

  • Jichi Medical University Saitama Medical Center

    RECRUITING

    Saitama, Saitama, Japan

  • Kagawa University Hospital

    RECRUITING

    Kita-gun Miki-cho, Kagawa-ken, Japan

  • Keijinkai Maruyama Clinic

    RECRUITING

    Sapporo, Hokkaido, Japan

  • Kitasato University Hospital

    RECRUITING

    Sagamihara, Kanagawa, Japan

  • Kobe University Hospital

    RECRUITING

    Kobe, Hyōgo, Japan

  • Kochi Kenshin Clinic

    RECRUITING

    Kochi, Kochi, Japan

  • Koganei Tsurukame Clinic

    RECRUITING

    Koganei, Tokyo, Japan

  • Kyoto Industrial Health Association

    RECRUITING

    Kyoto, Kyoto, Japan

  • Kyoto University Hospital

    RECRUITING

    Kyoto, Kyoto, Japan

  • Matsusaka Medical Association

    RECRUITING

    Matsusaka, Mie-ken, Japan

  • Medical Check Studio Tokyo Ginza Clinic

    RECRUITING

    Chuo-ku, Tokyo, Japan

  • Mie Healthcare center

    RECRUITING

    Tsu, Mie-ken, Japan

  • Mie University Hospital

    RECRUITING

    Tsu, Mie-ken, Japan

  • Miraza Shinjuku Tsurukame Clinic

    RECRUITING

    Shinjuku-ku, Tokyo, Japan

  • Mito Kyodo General Hospital

    RECRUITING

    Mito, Ibaraki, Japan

  • NEO Healthcare GI Endoscopy Clinic Honmachi

    RECRUITING

    Osaka, Osaka, Japan

  • Nagoya University Hospital

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • Nakagami General Chibana Clinic

    RECRUITING

    Okinawa, Okinawa, Japan

  • Nakagami Hospital

    RECRUITING

    Okinawa, Okinawa, Japan

  • Nihon University Itabashi Hospital

    RECRUITING

    Itabashi-ku, Tokyo, Japan

  • Obihiro Kosei Hospital

    RECRUITING

    Obihiro, Hokkaido, Japan

  • Oita University Hospital

    RECRUITING

    Yufu, Oita Prefecture, Japan

  • Okinawa Health Promotion Foundation

    RECRUITING

    Shimajiri-gun Haebaru-cho, Okinawa, Japan

  • Public Interest Incorporated Foundation Yamagata Health Promotion Organization

    RECRUITING

    Yamagata, Yamagata, Japan

  • Seirei Hamamatsu General Hospital

    RECRUITING

    Hamamatsu, Shizuoka, Japan

  • Seirei Preventive Health Care Center

    RECRUITING

    Hamamatsu, Shizuoka, Japan

  • Shiga University of Medical Science Hospital

    RECRUITING

    Ōtsu, Shiga, Japan

  • Shinjuku Tsurukame Clinic

    RECRUITING

    Shinjuku-ku, Tokyo, Japan

  • St. Marianna University School of Medicine Hospital

    RECRUITING

    Kawasaki, Kanagawa, Japan

  • Tane Clinic

    RECRUITING

    Osaka, Osaka, Japan

  • Tane General Hospital

    RECRUITING

    Osaka, Osaka, Japan

  • Teine Keijinkai Hospital

    RECRUITING

    Sapporo, Hokkaido, Japan

  • The Jikei University Hospital

    RECRUITING

    Minato-ku, Tokyo, Japan

  • Tokyo Women's Medical University Hospital

    RECRUITING

    Shinjuku-ku, Tokyo, Japan

  • Wakayama Medical University Hospital

    RECRUITING

    Wakayama, Wakayama, Japan

  • Yamagata University Hospital

    RECRUITING

    Yamagata, Yamagata, Japan

  • Yokohama City University Medical Center

    RECRUITING

    Yokohama, Kanagawa, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.